Definitive Healthcare Corp. (DH) came out with quarterly earnings of $0.06 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.08 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +2.92%. A quarter ago, it was expected that this company would post earnings of $0.06 per share when it actually produced earnings of $0.07, delivering a surprise of +16.67%.Over the last four quarters, the company ha ...

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...

Definitive Healthcare (NasdaqGS:DH) Q4 2025 Earnings call February 26, 2026 05:00 PM ET Company ParticipantsCasey Heller - CFOJonathan Paris - Chief Legal Officer and SecretaryKevin Coop - CEO and Board MemberConference Call ParticipantsBrian Peterson - Managing Director and Senior Equity Research AnalystGeorge Hill - Managing Director and Senior Equity Research AnalystJared Haase - Equity Research AnalystJeff Garroff - Equity Research AnalystMatt Shea - Equity Research AnalystNone - AnalystJonathan ParisGo ...

Definitive Healthcare (NasdaqGS:DH) Q4 2025 Earnings call February 26, 2026 05:00 PM ET Company ParticipantsCasey Heller - CFOJonathan Paris - Chief Legal Officer and SecretaryKevin Coop - CEO and Board MemberConference Call ParticipantsBrian Peterson - Managing Director and Senior Equity Research AnalystGeorge Hill - Managing Director and Senior Equity Research AnalystJared Haase - Equity Research AnalystJeff Garro - Equity Research AnalystMatt Shea - Equity Research AnalystNone - AnalystJonathan ParisGood ...

Definitive Healthcare (NasdaqGS:DH) Q4 2025 Earnings call February 26, 2026 05:00 PM ET Speaker5Good afternoon. Thank you for joining us today to review Definitive Healthcare's financial results. Joining me on the call today are Kevin Coop, Chief Executive Officer, and Casey Heller, Chief Financial Officer. During this call, we will make forward-looking statements, including, but not limited to, statements related to our market and future performance and growth opportunities, the benefits of our differentia ...

Cautionary statement regarding forward-looking statements This presentation includes forward-looking statements that reflect our current views with respect to future events and financial performance. Such statements are provided under the "safe harbor" protection of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that do not relate solely to historical or current facts, and can generally be identified by words or phrases written in the future tense and ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 001-40815 Definitive Healthcare Corp. (Exact name of Registrant as specified in its Charter) Delaware 86-3988281 (State or other jurisdic ...

Exhibit 99.1 Definitive Healthcare Reports Financial Results for Fourth Quarter and Full Fiscal Year 2025 Fourth quarter and full year 2025 revenue exceeded guidance Framingham, MA (February 26, 2026) – Definitive Healthcare Corp. ("Definitive Healthcare" or the "Company") (Nasdaq: DH), an industry leader in healthcare market data and analytics, today announced financial results for the quarter and full year ended December 31, 2025. Fourth Quarter 2025 Financial Highlights: Full Year 2025 Financial Highligh ...

Fourth quarter and full year 2025 revenue exceeded guidanceFRAMINGHAM, Mass., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (Nasdaq: DH), an industry leader in healthcare market data and analytics, today announced financial results for the quarter and full year ended December 31, 2025. Fourth Quarter 2025 Financial Highlights: Revenue was $61.5 million, a decrease of 1% from $62.3 million in Q4 2024.Net Loss, inclusive of goodwill impairment charge ...

Core Viewpoint - Definitive Healthcare Corp. will report its financial results for Q4 and the full year ended December 31, 2025, on February 26, 2026, after market close [1]. Group 1: Financial Reporting - The financial results announcement will be followed by a conference call and webcast at 5:00 PM (ET) / 2:00 PM (PT) [1]. - A live audio webcast of the event will be available on Definitive Healthcare's Investor Relations website [2]. - A replay of the conference call will be accessible through March 26, 2026, with specific dial-in numbers provided for both domestic and international callers [2]. Group 2: Company Overview - Definitive Healthcare is a data and analytics company focused on the business side of healthcare, aiming to clarify the complex healthcare market [3]. - The company provides insights that help healthcare organizations and companies make informed and strategic decisions [3].